中药预防新型冠状病毒肺炎策略与分析  

Analysis and Strategy on Prevention Plan of Corona Virus Disease 2019 by Traditional Chinese Medicine

作　　者：倪力强[1] 陶弘武[2] 杨小林 张杰[3] 倪行健 NI Liqiang;TAO Hongwu;YANG Xiaolin;ZHANG Jie;NI Xingjian(Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;The Second Affiliated Hospital of Liaoning Traditional Chinese Medicine University,Shenyang 110034,Liaoning,China;The First Affiliated Hospital of China Medical University,Shenyang 110001,Liaoning,China;Shenyang Agricultural University,Shenyang 110866,Liaoning,China)

机构地区：[1]上海中医药大学,上海201203 [2]辽宁中医药大学附属第二医院,辽宁沈阳110034 [3]中国医科大学第一附属医院,辽宁沈阳110001 [4]沈阳农业大学,辽宁沈阳110866

出　　处：《中华中医药学刊》2020年第4期8-14,共7页Chinese Archives of Traditional Chinese Medicine

基　　金：国家中医药管理局基本中医药循证能力建设项目[国中医药科技(2019)130];辽宁省科技厅公益基金(20170019)。

摘　　要：目的分析当前用中药预防新型冠状病毒肺炎方案,为防控疫情提供参考。方法检索截至2020年2月15日国家及各省、自治区、直辖市及武汉市卫生健康委、中医药管理局发布的新型冠状病毒肺炎相关诊疗最新方案及国医大师、院士、知名中医临床专家等通过公开渠道发表的建议,人工逐一剔除不含中药预防的方案和建议。制定资料提取表,内容包括来源、发布时间、发布机构或人员、处方组成、用药方式、注意事项等。结果共检索到国家及各地区卫生健康委、中医药管理局相关诊疗方案23项、15名中医药专家个人建议,提供中药口服预防处方102条,其他方式预防方案17种。部分方案撰写不规范、不严谨、难以操作。分层分析显示,黄芪、金银花在各类预防方案出现的频次最高。结论应加大力度推动中药预防新型冠状病毒肺炎,并开展相关实验室研究与临床评价;应进一步规范各地诊疗方案;不同体质群体应给予不同预防方;黄芪、金银花、生姜值得关注。Objective To investigate the current prevention of corona virus disease 2019(COVID-19) with traditional Chinese medicine(TCM) for epidemic prevention.Method We manually screened the plans with TCM from the latest diagnosis and treatment plans of COVID-19 issued by the national, provincial, autonomous regional, Wuhan health commissions, the State Administration of Traditional Chinese Medicine and the suggestions published by TCM masters, academicians and TCM clinical experts before February 15 th, 2020. The information extraction table was made by concluding sources, time, organizations or workers, prescription compositions, medication methods and precautions.Results A total of 23 diagnosis and 15 individual suggestions of TCM experts were retrieved, and 102 prescriptions for oral prevention of TCM and 17 other prevention plans were provided. Some of program writings were not standard and difficult to apply. Results showed that Huangqi(Astragalus), Jinyinhua(honeysuckle) and Shengjiang(ginger) have the higher using frequency in various prevention programs.Conclusion The prevention of COVID-19 by traditional Chinese medicine should be promoted, and relevant laboratory research and clinical evaluation should be carried out. We should further standardize the diagnosis and treatment programs. Different physical groups should be given different preventive prescriptions. Huangqi(Astragalus), Jinyinhua(honeysuckle) and Shengjiang(ginger) should be noted.

关 键 词：新型冠状病毒(SARS-CoV-2) 新冠肺炎 中药预防 

分 类 号：R511[医药卫生—内科学] R259.631[医药卫生—临床医学]